The importance of ACE2 in regulating the cardiovascular system
A recently discovered homologue of the angiotensin-converting enzyme, ACE2, insensitive to ACE inhibitors, was found in rodents and humans. ACE2 is expressed mainly in the vasculature, heart and kidney. ACE2 removes a single amino acid of the carboxy terminal of peptides. In the renin-angiotensin-aldosterone system (RAAS), it is responsible for the conversion of angiotensin I (Ang I) and angiotensin II (Ang II) to Ang 1-9 and Ang 1-7, respectively. While ACE forms Ang II, a potent vasoconstrictor, ACE2 degrades this peptide to form Ang 1-7 which has an opposite action. Therefore, ACE2 counteracts ACE in the balance of vasopressor/vasodilator as well as heart and kidney function. The importance of ACE2 in physiological and pathophysiological conditions is unclear and is currently being studied.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2007 |
---|---|
Erschienen: |
2007 |
Enthalten in: |
Zur Gesamtaufnahme - volume:146 |
---|---|
Enthalten in: |
Harefuah - 146(2007), 9 vom: 25. Sept., Seite 703-6, 733 |
Sprache: |
Hebräisch |
---|
Beteiligte Personen: |
Raz, Ayelet [VerfasserIn] |
---|
Themen: |
ACE2 protein, human |
---|
Anmerkungen: |
Date Completed 07.01.2008 Date Revised 09.12.2020 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM174698003 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM174698003 | ||
003 | DE-627 | ||
005 | 20231223140508.0 | ||
007 | tu | ||
008 | 231223s2007 xx ||||| 00| ||heb c | ||
028 | 5 | 2 | |a pubmed24n0582.xml |
035 | |a (DE-627)NLM174698003 | ||
035 | |a (NLM)17969309 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a heb | ||
100 | 1 | |a Raz, Ayelet |e verfasserin |4 aut | |
245 | 1 | 4 | |a The importance of ACE2 in regulating the cardiovascular system |
264 | 1 | |c 2007 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 07.01.2008 | ||
500 | |a Date Revised 09.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A recently discovered homologue of the angiotensin-converting enzyme, ACE2, insensitive to ACE inhibitors, was found in rodents and humans. ACE2 is expressed mainly in the vasculature, heart and kidney. ACE2 removes a single amino acid of the carboxy terminal of peptides. In the renin-angiotensin-aldosterone system (RAAS), it is responsible for the conversion of angiotensin I (Ang I) and angiotensin II (Ang II) to Ang 1-9 and Ang 1-7, respectively. While ACE forms Ang II, a potent vasoconstrictor, ACE2 degrades this peptide to form Ang 1-7 which has an opposite action. Therefore, ACE2 counteracts ACE in the balance of vasopressor/vasodilator as well as heart and kidney function. The importance of ACE2 in physiological and pathophysiological conditions is unclear and is currently being studied | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
650 | 7 | |a EC 3.4.15.1 |2 NLM | |
650 | 7 | |a ACE2 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
700 | 1 | |a Gamliel-Lazarovich, Aviva |e verfasserin |4 aut | |
700 | 1 | |a Bogner, Ido |e verfasserin |4 aut | |
700 | 1 | |a Strigevsky, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Keidar, Shlomo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Harefuah |d 1946 |g 146(2007), 9 vom: 25. Sept., Seite 703-6, 733 |w (DE-627)NLM000070491 |x 0017-7768 |7 nnns |
773 | 1 | 8 | |g volume:146 |g year:2007 |g number:9 |g day:25 |g month:09 |g pages:703-6, 733 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 146 |j 2007 |e 9 |b 25 |c 09 |h 703-6, 733 |